
The Companys net loss for the third quarter of fiscal year 2006 was $739,000 or ($0.06)
per share, compared to net loss of $1.6 million or ($0.13) per share for the third quarter
of 2005 … 
Bring promise of tomorrows medicines and technologies today … 
Company reported net loss of $ (629,970) on net sales of $ 78,562 for the third quarter
ended September 30, 2006 ($0.01 per share) … 
Event will assist FDA in fact-finding by gathering top experts from science, industry, and
government at nation's leading nanotech conference … 
Goal is to embed technology in products and to sell to cell phone and portable device
manufacturers … 
New functionality in image analysis and bioinformatics, along with enterprise
enhancements, increase product breadth and usability … 
The Heterodimer Protein Technology and ProteomicProcessor were used to analyze single
chain antibodies from LANL … 
The company expands on its polymer additive strategy in quarterly report … 
New simulation tools, pipeline pilot components and scripting functionality will enable
customers to enrich and improve their scientific workflow practices … 
Breakthrough Twin Beam Technology Enables Dedicated TEM and STEM Sample Preparation with
More Artifact Free Sample Clarity and precise end point detection … 